In 2014, there were almost 2 million individuals in the United States who either abused or were dependent upon prescription opioids. It is estimated that approximately 25% of patients who receive long-term prescription opioids for noncancer pain suffer from addiction. Emergency departments in the United States treat approximately 1000 individuals daily for misusing prescription opioids. 4 Given these statistics, it is not surprising that state and federal legislators have become increasingly concerned. In 1918, the first state Prescription Drug Monitoring Program (PDMP) was created in New York. This PDMP monitored the use of cocaine, morphine, and heroin. 5 Oklahoma is recognized as having the first electronic drug monitoring program which was initiated in 1991. At its core, the PDMP is a repository which allows prescribers to search for controlled substance prescriptions made to an individual patient. Depending upon a state's regulations, pharmacists, law enforcement officials, and prescribers may receive unsolicited reports about opioid use by individual patients. The goal of the PDMP is to prevent patients from seeking multiple prescribers or practice sites for new opioid medication prescriptions and/or refills.
As of 2018, all 50 states and the District of Columbia have enacted legislation to create statewide PDMPs, although the levels ABBREVIATIONS: EMR, electronic medical record; HER, electronic health record; PDMP, prescription drug monitoring program of functionality of these databases vary considerably. Missouri's PDMP was enacted through a governor-initiated executive order in 2017, but it is not yet accessible to clinicians. The majority of PDMPs include federal Schedule II to IV medications, including narcotics, tranquilizers, and stimulants (Table 1 ). Access to the PDMP repository depends on each state's laws. The majority of states allow certain stakeholders to access PDMP reports, including licensed physicians, mid-levels, and pharmacists. In some situations, additional stakeholders such as law enforcement, regulatory boards, licensure boards, state Medicaid programs, or state medical examiners and coroners can access the PDMP for investigatory purposes. Entities conducting research may also receive PDMP data for analyses. 6 Currently, 34 states (Table 2) mandate checking a PDMP prior to prescribing opioids in clinical situations outside of chronic opioid use or addiction treatment. 7 There are studies described in the literature which have found that, in certain contexts, the PDMP can be helpful to identify problematic opioid use. These PDMPs have been associated with decreased quantity of oxycodone shipments, reduced prescription opioid admission rates for states with PDMPs, declines in opioid use among the disabled and Medicare beneficiaries, and diminished abuse among chronic pain patients. [8] [9] [10] The impact of the PDMP upon physician workflow has not been well described in the literature. As an online database, PDMP's were hoped to streamline workflow, and have the theoretical potential to be integrated into the electronic health record (EHR) that would allow prescribers the opportunity for seamless verification of a patient's opioid history. This possibility has thus far been largely elusive. Some clinicians have questioned the burdens placed by mandates requiring that clinicians check the PDMP for every patient, which, depending upon the state, requires logging in to a separate interface and then waiting several minutes to allow the database to query the patient. This process can add minutes to each patient encounter which can add time and undue burdens upon an already strapped clinical day. As patient-physician contact time is already stressed by a perceived need to move more quickly, adding time to check a PDMP has the potential to lessen the time spent with patients during patient care interactions. Due to the burgeoning opioid epidemic, many states have recently begun imposing unfunded mandates requiring physicians to verify the PDMP for every patient for whom opioids are prescribed. In this study, we present the first survey of the workflow impact, ease of use, and attitudes of practicing neurosurgeons towards PDMPs.
METHODS
A 30-question online survey was developed by a group of subject matter experts and vetted for appropriateness and ease of answering. This survey was then sent to 5668 members of the American Association of Neurological Surgeons. Survey recipients included residents, fellows, and practicing neurosurgeons. Six-hundred seventeen survey responses were received (11% response rate). STATA SE15 statistical software (StataCorp LLC, College Station, Texas) was utilized to analyze the results with a two-tailed t-test to assess for variance between respondent groups.
RESULTS
States With Mandatory PDMP use (n = 414) Use of PDMPs (Table 3) There was literacy among respondents who lived in states with a mandate to verify the PDMP. Of the 414 survey responders who practice in the 34 states where mandatory PDMP checks currently exist, 361 (87%) within this subgroup recognized they lived in a state with a PDMP, 305 (74%) have a PDMP account, but only 235 (57%) of this subgroup recognize that their state mandates PDMP use. The length, on average, of checking the PDMP was less than 2 min for 78 (19%), 3 to 5 min for 138 (33%) and 5 to 10 min for 53 (13%), and greater than 10 min for 18 (4%) of respondents from states with a PDMP mandate. Of respondents, 124 (30%) state they do not use a PDMP. (Table 4 ) Two-hundred eighteen respondents (53%) in states with a PDMP mandate tend to check the PDMP themselves and 171 (41%) have the information obtained by their mid-level provider (PA or NP). Of respondents in states with a PDMP mandate, 174 (42%) tend to check the PDMP during the initial visit and 151 (36%) check the PDMP during a postoperative check. Survey responders in states with mandatory reporting checked the PDMP more often than those in states without a mandate (P < .02). One hundred thirty-two (32%) felt that checking the PDMP adds time and creates disruptions to their workflow. The average number of patients queried by those in states with a PDMP mandate within a month is 0 to 25 for 230 (56%) and 26 to 50 for 85 (21%). The majority of respondents in states with a PDMP mandate stated that the PDMP was helpful in detecting multiple prescriptions, 217 (60%). Most respondents in states with a PDMP mandate felt that although checking the PDMP came at the expense of time spent communicating with a patient, the time commitment was worth it for 132 (32%). (Table 5) Of survey respondents, 196 (48%) in states with a PDMP mandate would recommend the PDMP to other physicians. Respondents who reside in states with a PDMP mandate assert that, when the PDMP is discussed with a patient, 145 (35%) stated that it sometimes results in a response of anger or denial from the patient.
Impact on Workflow

Response to Statements
States Without Mandatory PDMP use (n = 203)
Use of PDMPs (Table 3) There was poorer literacy among respondents who lived in states without a mandate to verify the PDMP. One hundred fortyone (69%) within this subgroup recognized they lived in a state with a PDMP, 85 (42%) have a PDMP account, and 27 (13%) erroneously believed that their state mandates PDMP use. The length, on average, of checking the PDMP was less than 2 min for 24 (12%), 3 to 5 min for 36 (18%), 5 to 10 min for 16 (8%), and greater than 10 min for 5 (2%) of respondents from states without a PDMP mandate. Of respondents, 118 (58%) do not use a PDMP. This was statistically different compared to states with a mandatory PDMP use law (P = .03).
Impact on Workflow (Table 4)
Sixty-three respondents (31%) in states without a PDMP mandate tend to check the PDMP themselves while 61 (30%) have the information obtained via their mid-level provider (PA or NP). Fifty respondents (25%) in states without a PDMP mandate tend to check the PDMP during the initial visit and 63 (31%) review it during a postoperative check. Forty-eight (24%), feel that the PDMP adds time to each clinical encounter, but the added time spent was worth it. The average number of patients 
Response to Statements (Table 5)
Eighty-five respondents (42%) in the subgroup of states without a PDMP mandate would recommend the PDMP. A greater percentage of respondents in the subgroup of states without a mandate endorsed the statement that when the PDMP is discussed with the patient, the patient often or sometimes may not return (64 respondents; 31%). Respondents who reside in states without a PDMP mandate assert that when the PDMP is discussed with a patient, it sometimes results in a response of anger or denial (58 respondents; 29%).
Demographics (Table 6)
Respondents across subgroups in states with and without a PDMP mandate were fairly well distributed in terms of age, gender, practice location, and type of practice (Table 6 ). There were no statistically significant differences among the subgroup demographics. 
DISCUSSION
Use of PDMPs and the Enactment Effect
A majority of respondents (87%) who reside in a state with a PDMP mandate recognize that they live in a state with a PDMP. Interestingly, since every state has a PDMP, this number should be 100% across groups. A majority of overall respondents (64%) also have a PDMP account. There was literacy among respondents, especially the subgroup with state mandated verification of a PDMP, with 57% of respondents recognizing that their state's PDMP verification is mandatory.
The literature is mixed in terms of the impact of mandatory PDMP verification. An analysis of 122 732 electronic medical records (EMRs) for patients discharged with an opioid prescription from 15 Emergency Departments in the state of Pennsylvania from 2015 to 2017 found that immediately after implementation of a state law mandating PDMP use, the opioid prescribing rate decreased. 11 A study of New York physicians found that the number of opioid prescriptions declined following mandatory verification laws; however, the total quantity of opioids in the supply chain increased and visits for heroin overdoses began to escalate in 2010 and continued to increase through 2016. 12 However, a study of drug overdoses across all drug categories, from 1999 to 2014, found PDMP enactment was not correlated with decreased rates of drug overdose or prescription opioid overdose mortality rates relative to states without PDMPs. 13 Another study showed that PDMP enactment was not related to changes in physician opioid prescribing for noncancer patients. 14 Over time, some states have shifted from mandatory registration ("signing up") through a PDMP to mandated use/verification for each patient. An analysis of Medicaid drug utilization data from 2011 to 2014 found that mandatory PDMP registration or verification was associated with a 10% reduction in Schedule II opioid prescriptions and decreased Medicaid spending; this effect was related to mandatory registration within a PDMP but not mandatory use, which tended to include few states or have weak regulations prior to 2015. 15 Since Missouri had been the lone state for several years without a PDMP, several studies attempted to project the benefit to Missouri adopting a PDMP. Prior to Missouri's enactment of PDMP legislation through executive order, it was forecasted that if Missouri had implemented a PDMP and states across the country strengthened their PDMP with stronger enforcement elements, 600 overdose deaths in 2016 may have been prevented. Enactment of a PDMP is associated with 1.12 fewer opioid-related deaths per 100 000 population following implementation. 16 A national survey on opioid analgesics and other pain medications in ambulatory care settings from 2001 to 2010 found that the implementation of a PDMP was correlated with a 30% decrease in Schedule II opioid prescribing, and this effect persisted in the second and third years following PDMP implementation. 17 A study of heroin abuse from 1992 to 2012 found that the association between hospital admissions for heroin and hospital admissions for prescription opioids was statistically significant following PDMP enactment. 18 Another study of unsolicited reports sent by the Massachusetts PDMP to prescribers from 2010 to 2011 found significantly greater decreases in the number of Schedule II opioid prescriptions (such as oxycodone), the number of prescribers visited, the number of pharmacies used, the total days' supply of medications, and the total morphine milligram equivalents for patients whose providers received an unsolicited report relative to a control group. 19 A paper on Medicare Part D prescribing data found that PDMPs were correlated with 5.2% fewer days' supply of prescribe oxycodone, with smaller decreases in hydrocodone and opioids noted overall. 20 In an assessment of 816 opioid overdose death rates between 1999 and 2014, even weaker regulatory PDMPs were associated with a reduction in overdose deaths relative to states without a PDMP. 21 
Impact on Workflow
Within the subgroup of respondents who live in a state with mandatory PDMP verification, 34% responded that it takes 3 to 5 min for the average patient to verify the PDMP. For 78 respondents (19%), the average time per patient was less than 2 min and for 53 (13%), the average time per patient was 5 to 10 min. In the context of a busy clinical day, this can be a considerable burden by lengthening an already saturated clinical schedule. For the majority of all respondents in our study (70%), the PDMP is a separate website and is not integrated through the EHR. This compromises workflow as a separate computer network that needs to be queried. For the majority of all respondents in our study (60%), the PDMP has helped identify patients with potential abuse issues by detecting when multiple prescriptions were written. Certainly, this can be helpful and may steer neurosurgeons away from prescribing or refilling opioid medications when the patient was already being treated elsewhere. Respondents were mixed in believing that the time spent checking the PDMP detracted from communicating with patients. For many of respondents in the subgroup who live in a state with mandatory PDMP verification, 50% check the PDMP at the time of the initial visit and 44% check it during the initial postoperative visit. Depending upon the type of surgery and the number of postoperative visits, this can be an additional burden and strain on time and workflow. For the majority (61%) of respondents in our survey in the subgroup who live in a state with mandatory PDMP verification, the average number of patients queried through the PDMP in a given month is 0 to 25. Thirty-three percent of respondents in our survey in the subgroup who live in a state with mandatory PDMP verification felt that it adds time and creates disruptions in workflow. A 2014 survey of PDMP administrators across 49 states with a PDMP found that 57% reported a delay of up to 1 wk or more for patients to appear in a PDMP after filling a prescription. 22 The majority of overall respondents (281; 56%) in our study verify the PDMP themselves instead of having this done by mid-level practitioners (232; 46%) or residents (26; 5%). A study of 5935 prescribers registered through the Oregon PDMP from 2011 to 2014 found that patients of nurse practitioners or doctors of nursing received more high-risk opioid prescriptions than patients of MDs/DOs/PAs. This increase included more high-dose prescriptions and also a greater incidence of opioidrelated hospitalizations. 23 A study of New York physicians following the 2013 mandated verification through ISTOP-the Internet System for Tracking Over-Prescribing-found that most prescribers were frustrated by the login process, the complexity of querying patients, the lack of integration with EMR, the time burden, and the potential for under-treatment. 24 Alleviating pain is an essential humanistic component of the profession of medicine. While PDMPs provide the structure to flag potentially dangerous opioid use, this must be balanced against providing necessary pain relief for patients with conditions that require it. Ethical considerations surrounding clinical decision-making and the use of opioids and other analgesics have a myriad of complexities and should account for parameters such as clinical condition, medical history, age, sex, drug-drug interactions, and history of addiction or diversion. 25 Future directions for PDMP innovation and advancement should include improved data sharing capabilities across state lines, integration of PDMP data with the EHR, and improved training for PDMP end users. 26 Alternatively, creation of a national PDMP has been discussed as a possible solution to multiple state prescription issues.
Ultimately, while the PDMP plays an important role in identifying patients with potentially problematic opioid use, the impositions on day-to-day neurosurgical clinical workflow and barriers to accessibility can limit the widespread use and efficacy of the PDMP. Time will tell if the system can be improved to successfully provide more positive patient benefits and overcome current impositions on the physician-patient relationship.
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